Introduction
The multifunctional growth factors, acidic and basic ®broblast growth factors (FGF-1 and FGF-2 respectively) are members of a larger family which currently consists of nine related polypeptides (Basilico and Moscatelli, 1992; Miyamoto et al., 1993) . FGF-1 and FGF-2 are mitogenic for a number of cell types including ®broblasts (Gospodarowizc et al., 1987) and endothelial cells (Moscatelli et al., 1986) . They are also potent antiogenic factors (Folkman and Klagsbrun, 1987) and have multiple roles during embryonic development and morphogenesis (Johnson and Williams, 1993) .
Unlike the other members of the FGF family, FGF-1, FGF-2 and FGF-9 lack a conventional signal peptide sequence for secretion (Gospodarowizc et al., 1987; Miyamoto et al., 1993) . It is becoming increasingly clear however that FGF-2 can be released from living cells, thus allowing activation of its own high anity receptors. In some instances, antibodies directed against FGF-2 inhibit its biological function thereby supporting an autocrine or paracrine mechanism of action (Sato and Rifkin, 1988; Mignatti et al., 1991) . The mechanism of secretion of FGF-2 remains largely unknown, but several hypotheses have been put forward (reviewed in D' Amore, 1990) . Recently, a novel energy-dependent membrane-associated transport pathway speci®c for FGF-2 has been reported (Florkiewicz et al., 1995) . Interestingly, FGF-9, which has an N-terminal structure resembling that of FGF-1 and FGF-2, (i.e. devoid of a signal sequence) was also found to be secreted by a non-conventional route. (Miyamato et al., 1993) .
Although FGF-1 and FGF-2 are potent mitogens for a wide spectrum of cells, the transforming ability and the oncogenic potential of these growth factors are highly dependent upon the cell type and the level of synthesis, and also appears to be strongly dependent on whether or not they are secreted (Basilico and Moscatelli, 1992) . Most of the experiments carried out with transfected NIH3T3 cells have shown that transformation by FGF-1 and FGF-2 can be achieved when high levels of the growth factor are produced or when the growth factor is secreted, suggesting that cellular transformation results from the activation of an autocrine loop (Forough et al., 1993; Quarto et al., 1989; Rogelj et al., 1988; Sasada et al., 1988) .
Tumor development mediated by FGF-1 and FGF-2 may be a consequence of their dual function as angiogens and oncogenes. The role of FGFs on inducing tumor vascularization is well documented (Folkman and Klagsbrun, 1987) , whilst their possible role as oncogenes remains elusive (Basilico and Moscatelli, 1992) . In vitro, members of the FGF family which are secreted have oncogenic potential. An in vivo correlation with carcinogenesis has only been documented for the mouse mammary tumor int-2 (FGF-3) (Peters et al., 1984; Sonnenberg et al., 1987) .
In this study, we compare the tumor-forming abilities of the rat bladder carcinoma cells, NBT-II, transfected with cDNAs encoding FGF-1 or FGF-2.
We demonstrate that FGF-2 is secreted by the cells in a biologically active form, although the cDNA sequence used for transfection is devoid of a signal peptide. The FGF-2 producing cells were no more tumorigenic in nude mice than the parental cells, but the resultant carcinomas are highly vascularized, indicating that the FGF-2 secreted by the carcinoma cells induces strong in vivo angiogenesis. These ®ndings dier from those obtained with NBT-II cells producing FGF-1, which are not only potently angiogenic but are also much more highly tumorigenic in nude mice than the parental cells.
Results

FGF-2 is secreted by NBT-II transfected cells
A number of stable clones of FGF-2-transfected NBT-II cells have been obtained. These clones were all, like the parental NBT-II cells, of epithelial morphology and produce amounts of FGF-2 ranging from 1.5 to 35 ng per 10 7 cells in subcon¯uent culture. We have chosen to conduct further work with cells that produce a relatively high level of growth factor, i.e. the bGF22 and the bGF11 clones. Immuno-enzymoassay performed on total cell extracts showed that bGF22 cells produce 22 ng/10 7 cells and bGF11 clone 20 ng/10 7 cells after a 3 day period of culture in vitro. FGFR1-transfected NBT-II cells cultured in the presence of medium conditioned by bGF22 cells scatter within 1 ± 2 days (Figure 1b) , whereas the same medium is unable to induce scattering of the NBT-II parental cells (not shown). This is presumably due to the lack of a receptor able to recognize FGF-2 (Savagner et al., 1994) . Neutralizing antibodies against FGF-2 abolish almost completely the scattering activity of bGF22 conditioned medium on FGFR1-transfected cells (Figure 1c) , con®rming the presence of biologically active FGF-2. As a control, FGF-1 speci®c blocking antibodies did not alter cell morphology (not shown).
The presence of active FGF-2 in the bGF22 conditioned medium was also established by using bovine brain capillary (BBC) endothelial cells, which are dependent upon a growth factor, such as FGF-2, for proliferation. The medium conditioned by FGF-2 transfected cells contains a mitogenic activity for BBC cells ( Figure 2) ; furthermore, antibodies against FGF-2 reduced by 50% the mitogenic activity of the bFG22 medium, whereas FGF-1 or vascular endothelial growth factor (VEGF)-speci®c neutralizing antibodies had no eect (not shown). Taken together these results show that NBT-II cells transfected with an FGF-2 construct devoid of a signal peptide, secreted a growth factor able to induce cell scattering and cell proliferation. 
Production and secretion of VEGF by NBT-II cells
Medium conditioned by NBT-II cells secreting FGF-1 (clone SP30) or FGF-2 (clone bGF22), and control NBT-II carcinoma cells were tested for the presence of VEGF, another potent angiogenic factor, by using a radioreceptor assay (RRA). The SP30, bGF22 and NBT-II media conditioned by an equal number of cells, contained 4.7 ng/ml, 0.7 ng/ml and 13 ng/ml of VEGF, respectively. This result suggests that the constitutive production of angiogenic factors such as FGF-1 or FGF-2 by NBT-II cells may down-regulate at least in vitro, the production of VEGF by tumor cells.
FGF-2-producing NBT-II cells are no more tumorigenic than control cells
Although FGF-2-producing cells are tumorigenic in nude mice, the latency period, of 6 weeks, is similar to that observed in NBT-II cells transfected with the bgalactosidase reporter gene ( Figure 3 ). Animals injected with control and FGF-2-producing cells developed carcinomas with similar growth kinetics, but tumors resulting from the latter were highly vascularized with a high density of enlarged vessels ( Figure 4 and Table 1 ). These features are similar to the ones of tumors obtained with NBT-II cells producing FGF-1 . These results demonstrate that secreted FGF-1 and FGF-2 are potent angiogenic factors for NBT-II tumors, but also indicate that strong angiogenesis is not sucient to accelerate tumorigenesis. Counterstaining of the tumor sections showed clearly that FGF-2-producing cells, as well as the control NBT-II cells, give rise to carcinomas consisting of typical groups of tumor cells surrounded by connective tissue stroma ( Figure 4 ). Tumors obtained with FGF-1-producing cells are almost devoid of stromal tissue, probably due to the very rapid take of the tumor and subsequent proliferation of the carcinoma cells.
A small number of FGF-1-producing NBT-II cells are able to promote enhanced tumorigenesis of parental NBT-II cells, a phenomenom which we have referred to as the community eect . In contrast, FGF-2-producing cells do not induce such a community eect when mixed with NBT-II cells expressing the FGFR1 receptor, and the kinetics of tumor growth are similar to those of control cells (Figure 3 ). These results demonstrate that FGF-2 is not sucient to induce a community eect within the carcinoma and to confer increased tumorigenic properties to NBT-II cells, even if most of the cells express the appropriate receptor. (Savagner et al., 1994) . FGF-1 and FGF-2 lack a signal sequence, and as a consequence these polypeptides cannot be secreted into the culture medium via the conventional route. It has been demonstrated that even in the absence of a signal sequence, in some circumstances, low levels of FGF-2 can be found in the culture medium of producing cells (D'Amore, 1990). Unlike FGF-1 and FGF-2, four oncogene products that belong to the FGF family (i.e. FGF-3/Int-2, FGF-4/hst, FGF-5 and FGF-6) possess signal peptides and are secreted. Interestingly, it has been proposed that these oncogenes may be involved in malignant autocrine transformation and that the presence of a signal sequence may be a prerequisite for a growth factor to act as a transforming oncogene (Yayon et al., 1990) . The molecular mechanism by which FGF-2 is exported is still unknown. It has been demonstrated that viable transfected NIH3T3 cells secrete FGF-2, and that this serves to stimulate their migration via an autocrine mechanism . Recent ®ndings have shown that FGF-2 devoid of a signal peptide could be exported via an energydependent cellular pathway distinct from the classical signal peptide-mediated secretion (Florkiewicz et al., 1995) . This hypothesis remains to be tested in the case of FGF-transfected NBT-II cells.
We have demonstrated that despite the absence of a signal sequence, FGF-2 can be exported from NBT-II cells by a still unknown mechanism. As reported previously, FGF-2 does not induce scattering of NBT-II cells (ValleÁ s et al., 1990) . In sharp contrast, NBT-II cells stably expressing the FGFR1 receptor become responsive to FGF-2 and scatter readily in a manner similar to parental NBT-II cells in the presence of FGF-1. The growth factor secreted by bGF22 cells induces scattering of FGFR1(Flg)-expressing cells and stimulates markedly the growth of endothelial cells. These results indicate that FGF-2, which is probably not secreted via the classical pathway, accumulates in a biologically active form in medium conditioned by the FGF-2-transfected cells.
In the last decade many laboratories have investigated the putative role of FGF-1 and FGF-2 in cell transformation and tumorigenesis. Fibroblasts transfected with FGF-1 or FGF-2 cDNAs, either with or without a signal sequence, show dierent behaviors depending on the cell type. NR6 cells expressing FGF-1 appear morphologically transformed in vitro, but form only small non-progressive tumors when injected subcutaneously into nude mice (Jaye et al., 1988) . Similarly, NIH3T3 cells expressing a non-secreted form of FGF-1 produce tumors in nude mice, but their appearance is delayed. Similar experiments performed with a secreted form of FGF-1 clearly show that the ability of FGF-1 to transform NIH3T3 cells requires the secretion of FGF-1, and increases their tumorigenicity in vivo (Forough et al., 1993) . Interestingly, it has been reported that FGF-1 is not sucient by itself to confer tumorigenic properties on normal cells, but rather acts as a progression factor which enhances the tumorigenic potential of partially transformed cells in the rat-1 system (Takahashi et al., 1992) . In this work, we have demonstrated that FGF-2-producing cells are no more tumorigenic than the parental NBT-II cells. It has been reported that FGF-2 may be tumorigenic when the short 18 Kd form or the high molecular weight form are expressed at high levels in NIH3T3 cells (Quarto et al., 1989 (Quarto et al., , 1991 . Cooperation between the high molecular weight forms (22.5 and 21 kDa), which both contain the nuclear localization sequence (Bugler et al., 1991) , and the 18 kDa form of FGF-2 is required for inducing oncogenic potential in normal adult bovine aortic endothelial cells (Couderc et al., 1991) . The FGF-2 expressed in NBT-II transfected cells is the 18 kDa form which cannot be targeted to the nucleus. Although the growth factor is produced in large amounts no stimulation of the tumorigenic properties of the cells was observed. At the present time there is no evidence that the nuclear form of FGF-2 may be more tumorigenic in the NBT-II system. VEGF has been reported to act in synergy with FGF-2 in the induction of angiogenesis in vitro (Pepper et al., 1992) . Although exogeneously added FGF-2 might upregulate VEGF expression (Tsai et al., 1995) , our results indicate that constitutive expression of FGF-1 or FGF-2 regulates VEGF expression leading to a reduced concentration. However VEGF content of cell cultured in vitro does not necessarily re¯ect their angiogenic and tumorigenic potential since hypoxia might modulate in vivo VEGF expression dierently from one cell line to the other. In vivo however these cells produce highly vascularized tumors suggesting that VEGF cannot be the only factor required for the activation of tumor angiogenesis (Christofori et al., 1995) . We cannot however, exclude the possibility that other angiogenic factors cooperate with FGF-2 (Folkman, 1995) .
We have reported previously that irrespective of whether it is secreted, FGF-1-expressing cells give rise to rapidly growing tumors which are extremely vascularized in nude mice . We have shown that as few as one thousand FGF-1-producing cells mixed with 3.5610 6 non-producing cells confers an increased tumorigenicity to the whole cell population, via a community eect mediated by FGF-1 . Interestingly, SFL (scatter factor like) a recently described scattering activity naturally produced by a metastatic variant of NBT-II cells (Bellusci et al., 1994) , is also able to induce a community eect through a mechanism of cell
FGF-1, FGF-2, angiogenesis and tumor proliferation J Jouanneau et al cooperation, the nature of which remains to be determined (Bellusci et al., 1995) . The molecular mechanism responsible for the propagation of the signal remains to be elucidated. It appears however, that little, if any, FGF-1 is secreted by these cells. It was therefore of interest to determine whether FGF-2 could also mediate a community eect. FGF-2 produced by the transfected NBT-II cells cannot establish an autocrine or paracrine loop, since NBT-II cells lack its cognate receptors. To create a paracrine situation, nude mice were injected with mixtures of FGF-2-producing cells (bGF22 cells) and NBT-II cells expressing functional FGFR1 receptors (¯g receptor). A community eect similar that one observed with FGF-1 was not observed. These results provide additional evidence that although FGF-2 is a potent inducer of tumor neovascularization, it is not sucient to accelerate tumor development.
Materials and methods
Cells
NBT-II cells are derived from a chemically-induced rat bladder carcinoma (Toyoshima et al., 1971) . These epithelial cells do not produce endogeneous FGF-1 nor FGF-2 but express approximately 5000 high anity receptors per cell (ValleÁ s et al., 1990) ; this FGF receptor has been cloned and identi®ed as FGFR2b, a splice variant of the Bek receptor (Savagner et al., 1994) . Transfected NBT-II cells expressing FGF-1 or the FGFR1 receptor (Flg) have been reported elsewhere (Jouanneau et al., 1991; Savagner et al., 1994) ; NBT-II cells expressing the FGFR1 are able to respond biologically to exogenous FGF-2 and to scatter in vitro, whereas untransfected cells do not respond to FGF-2 (Savagner et al., 1994) .
Antibodies
Antibodies against FGF-1 and FGF-2 are non-crossreacting rabbit polyclonal neutralizing antibodies puri®ed on protein A. Anti VEGF is an anity puri®ed rabbit polyclonal antibody (Plouet and Moukadiri, 1990) .
Expression plasmid for FGF-2
The cDNA coding for bovine FGF-2 was cloned initially in pBR322 (Abraham et al., 1986) . The 1.4 Kb EcoRI fragment containing the entire coding sequence and beginning approximately 100 bp upstream of the ATG start codon was subcloned in the pCMV expression vector (Jaye et al., 1988) , and termed pFGF-2.
Transfections 10 6 NBT-II cells were seeded in 10 cm diameter dishes 24 to 48 h before transfection. Cells were transfected with 20 mg of pFGF-2 and with 2 mg of the selective marker pAG60Neo (ColbeÁ re-Garapin et al., 1982) according to the calcium-phosphate co-precipitation technique (Graham and Van der Eb, 1973) . Cells were selected for the expression of the Neo resistance gene with G418 (Gibco-BRL) at a concentration of 400 mg/ml of active geneticin.
Mitogenic activity on endothelial cells
2.5610
4 bovine brain capillary cells (BBC) were plated in duplicate in 1 cm 2 culture wells with 1 ml of standard medium and incubated at 378C for various periods. BBC cells were grown either in standard medium, or in medium containing various amounts of 1006 concentrated medium conditioned either by control NBT-II cells, FGF-1-or FGF-2-secreting cells. The FGF-1-secreting cells correspond to the SP30 clone of NBT-II cells transfected with an FGF-1 cDNA construct containing a signal peptide sequence (Jouanneau et al., 1991) . The BBC cells were trypsinized and counted. Under standard conditions endothelial cells remain almost quiescent (data not shown). Inhibition of cell growth was performed by adding rabbit polyclonal anti-FGF-2 antibodies at a concentration of 50 mg/ml. Control experiments were performed with anti-FGF-1 antibodies.
Radioreceptor assay for VEGF (RRA)
RRA to detect VEGF secretion was performed on media conditioned by untransfected and FGF-1 and FGF-2-transfected cells as reported previously (Plouet and Moukadiri, 1990 ). An identical number of cells were grown to sub-con¯uency, the medium was removed, and the cells were incubated for another 24 h in fresh medium; this medium is referred to as conditoned medium.
20 ml of conditioned medium was diluted with an equal volume of 10 mM Tris pH 7.2, and stirred at 48C with 0.1 ml of heparin-Sepharose (Pharmacia). After 2 h the heparinSepharose was collected by centrifugation, washed with 10 mM Tris, 50 mM NaCl pH 7.2, and the bound material eluted with 1 M NaCl. VEGF content was measured by RRA using fetal bovine aortic endothelial cells as target cells (Plouet and Moukadiri, 1990 ).
Enzymo-immuno assay for FGFs (EIA)
Production of FGF-1 by NBT-II transfected cells has been reported previously, and was assayed by a solid phase EIA (Caruelle et al., 1989) . NSF14 cells produce 166 ng/10 7 cells of FGF-1 and do not secrete the growth factor. SP30 cells (NBT-II cells transfected with a hybrid construct of FGF-1 and a signal peptide) produce (208 ng/10 7 cells) and secrete (305 ng/10 7 cells/24 h) the growth factor (Jouanneau et al., 1991 . Production of FGF-2 by transfected clones was assayed by a similar EIA. Assays were carried out on total cellular extracts after puri®cation of the growth factor by heparin-Sepharose anity chromatography.
Induction and inhibition of the FGF-induced scattering activity FGF-2 is able to induce cell scattering of FGFR1 expressing cells in a manner similar to that of FGF-1 in NBT-II parental cells (Savagner et al., 1994) . 5610 4 cells were seeded (24 multiwell plates) in standard medium or in the presence of medium conditoned either by NBT-II or bGF22 cells. Parallel experiments were carried out by adding speci®c blocking antibodies against FGF-1 (80 mg/ ml) or FGF-2 (75 mg/ml). Cells were incubated for 48 h and their morphology observed by light microscopy.
Tumorigenicity in nude mice
Groups of 6 week-old female nude mice (nu/nu Swiss strain, Ia Credo, Les Oncins, France) were subcutaneously injected in the¯ank with control NBT-II cells, FGF-1 producing cells (clone NSF14) and FGF-1 secreting cells (clone SP30), FGF-2 producing cells (clone bGF22), FGFR1-expressing cells (clone Flg8) or a mixture of bGF22 (0.5610 6 cells) and FGFR1-expressing cells (3.0610 6 cells). In all cases a total of 3.5610 6 cells were injected. Tumor volumes were monitored every two days during the ®rst 2 weeks and once a week thereafter. After euthanasia, tumors were removed and carefully analysed for their angiogenic status; the animals were examined routinely for macroscopic metastatic foci in various internal organs.
Von Willebrand immunostaining and vascularization of the tumors
Fragments of tumors were placed directly into OCT embedding medium (Tissue-Tek), frozen on liquid nitrogen-cooled isopentane, cryosectioned, and stored at 7808C. Acetone-®xed sections were stained for endothelial cells with rabbit anti-Von-Willebrand factor antibodies followed by peroxidase-conjugated goat anti-rabbit immunoglobulin (Dakopatts). Von Willebrand stained vessels of ®ve independent ®elds of stained sections (mean of two to three sections) were counted and the capillary density was determined in each case.
